San Diego Smartphone Factory FTZ Plan Suddenly Withdrawn

2026-19699, Foreign-Trade Zone (FTZ) 57, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Concord, North Carolina

Eli Lilly wants to start making several important drug products at their Concord, North Carolina facility under special Foreign-Trade Zone rules. This move helps them save on import duties for certain materials while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The government got their request on September 17, 2026, and is reviewing it to give the green light soon.

2026-19698, Foreign-Trade Zone (FTZ) 93, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Durham, North Carolina

Eli Lilly wants to start making several special drug products at their Durham, North Carolina facility under Foreign-Trade Zone 93. This means they can use certain imported materials without paying duties while producing medicines for diabetes, migraines, inflammation, weight management, and Alzheimer's. The change could speed up production and save money, with the proposal officially received on September 17, 2026.

2026-19589, Foreign-Trade Zone (FTZ) 40, Notification of Proposed Production Activity; Olon USA LLC; (Active Pharmaceutical Ingredients); Concord, Ohio

Olon USA LLC in Concord, Ohio wants to start making special cancer and kidney treatment ingredients in Foreign-Trade Zone 40. This means they can save money on import duties for certain materials, with rates between 3% and 6.5%. People have until November 3, 2026, to share their thoughts before the plan gets the green light.

2026-19593, Foreign-Trade Zone 57; Approval of Subzone Status; AUMOVIO Systems, Inc.; Morganton, North Carolina

AUMOVIO Systems in Morganton, North Carolina, just got the green light to become a special part of Foreign-Trade Zone 57, called Subzone 57J. This means they can enjoy benefits like easier customs rules, helping their business grow without extra costs. The approval happened on September 21, 2026, and fits within the zone’s size limits, so things are set to roll smoothly!

2026-19591, Foreign-Trade Zone (FTZ) 272, Notification of Proposed Production Activity; Infinera Corporation; (Telecommunications Devices); Allentown, Pennsylvania

Infinera Corporation in Allentown, PA, wants to make special fiber optic parts in Foreign-Trade Zone 272, which means they can save on import taxes for certain materials. This change helps Infinera build cool telecom devices like Optical Transmit/Receive Subassemblies and Transceiver Photonic Integrated Circuits more cheaply and efficiently. The government is reviewing this now, so keep an eye out for updates soon!

2026-19592, Foreign-Trade Zone 57, Notification of Proposed Production Activity; AUMOVIO Systems, Inc.; (Electronic Braking, Suspension, Hydraulic, Pneumatic, and Related Automotive Components and Systems); Morganton, North Carolina

AUMOVIO Systems in Morganton, NC, wants to make car parts like brakes and suspension components using some imported materials under special trade rules. This move could save them money on import duties, with rates from zero to 2.5%. The government is reviewing this plan, which was officially submitted in early September 2026.

Previous: 2026-16353, Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. GDUFA amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) to authorize FDA to assess and collect fees to support human generic drug activities. The current legislative authority for GDUFA expires at the end of September 2027. At that time, new legislation will be required for FDA to continue to assess and collect generic drug user fees for future fiscal years. The FD&C Act directs FDA, following negotiations with the regulated industry and periodic consultations with other stakeholders, to present recommendations for reauthorization of the GDUFA program to the relevant Congressional committees, publish the recommendations in the Federal Register, provide for a period of 30 days for the public to provide written comments on such recommendations, and hold a meeting at which the public may present its views on such recommendations. FDA will then consider such public views and comments and revise such recommendations as necessary.

Next: 2026-16356, Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; Viatris Pharmaceuticals LLC; (Medications); Vega Baja, Puerto Rico

Viatris Pharmaceuticals in Vega Baja, Puerto Rico, wants to make several medicines using special foreign materials in a Foreign-Trade Zone (FTZ 61). This means they can save on import duties, helping them produce drugs like Ativan, Lipitor, and Xanax more cost-effectively. The government is asking for public comments before approving this plan, which could impact local jobs and medicine prices soon.